Company
Boston Scientific Corp BSX
Tracked across 9 disclosed holders on Protégé.
7 tracked investors, latest 13F quarter ending 30 Jun 2026 · 2 members of Congress · latest filing 25 Sep 2026
Held by these investors
| Investor | Weight in portfolio | Value (13F) | Quarter ending |
|---|---|---|---|
| Farallon Capital Management | 2.7% | $449.0M | 2026-06-30 |
| Maverick Capital | 2.3% | $253.4M | 2026-06-30 |
| D. E. Shaw & Co. | 0.7% | $1.1B | 2026-06-30 |
| Two Sigma Investments | 0.6% | $826.2M | 2026-06-30 |
| Voloridge Investment Management | 0.6% | $139.8M | 2026-06-30 |
| Walleye Capital | 0.3% | $67.4M | 2026-06-30 |
| Schonfeld Strategic Advisors | 0.3% | $56.6M | 2026-06-30 |
Members of Congress who disclosed trades
| Politician | Disclosed activity | Est. net |
|---|---|---|
| Kevin Hern | 0 buys / 6 sells | -$207K |
| Gilbert Cisneros | 7 buys / 1 sell | $48K |
Sources: SEC EDGAR (Form 13F-HR and Form 4) and the official House and Senate STOCK Act disclosures. Filings are quarterly or delayed, so current holdings may differ. Weights are each holder's own portfolio share, not a share of the company.